Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jul 6, 2021
Document Date
Jun 23, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
BASTA JAMES